Back

Q&A.

1 September 2020 (18:49 - 18:52)
Organised by:
Congress Presentation Part of: Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios Venous Thromboembolism Open Access ESC Congress 2020

6 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor S. Konstantinides (Mainz, DE)
Video
Presentation thumbnail
Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.
Professor S. Konstantinides (Mainz, DE)
Video
Presentation thumbnail
Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.
Professor J. Weitz (Hamilton, CA)
Video
Presentation thumbnail
Q&A.
Video
Presentation thumbnail
Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?
Professor A. Khorana
Video

Access the full session

Session thumbnail
Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios
Video

The Event

Event poster

ESC Congress 2020

1 September 2020 18:49 CET
You may be interested in
thumbnail
Congress Presentation
EAS Consensus on Lp(a) 2022- What to measure, in whom to measure, how to interpret and what to do - Q&A .
29 August 2022
thumbnail
Congress Presentation
Conclusion
30 August 2025
thumbnail
Congress Presentation
Summary.
29 August 2022
thumbnail
Congress Presentation
Structural heart disease in the transcatheter era: what the ESC/EACTS 2025 Guidelines mean for today’s practice - conclusion
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources